Review
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Dec 24, 2015; 5(4): 183-195
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.183
Cardiovascular risk factors following renal transplant
Jill Neale, Alice C Smith
Jill Neale, Alice C Smith, Leicester Kidney Exercise Team, John Walls Renal Unit, Leicester General Hospital, Leicester LE5 4PW, United Kingdom
Jill Neale, Alice C Smith, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester LE1 9HN, United Kingdom
Author contributions: Neale J wrote the paper; Smith AC reviewed the paper.
Supported by National Institute for Health Research Diet, Lifestyle and Physical Activity Biomedical Research Unit based at University Hospitals of Leicester and Loughborough University.
Conflict-of-interest statement: Authors declare no conflict of interests for this article.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Jill Neale, BSc, MBBS, MRCP, Academic Clinical Fellow, Department of Infection, Immunity and Inflammation, University of Leicester, University Rd, Leicester LE1 9HN, United Kingdom. jn150@student.le.ac.uk
Telephone: +44-116-2584346
Received: June 9, 2015
Peer-review started: June 14, 2015
First decision: August 4, 2015
Revised: August 19, 2015
Accepted: September 25, 2015
Article in press: September 28, 2015
Published online: December 24, 2015
Core Tip

Core tip: Cardiovascular disease (CVD) is the leading cause of death and disability in patients following a renal transplant. Identification of risk factors for CVD and strategies for their improvement are required in order to prevent graft failure in this complex patient group. This review identifies the most important risks for CVD and seeks evidence for how they can be most successfully managed and modified to improve morbidity and mortality.